Open AccessEffectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
Author(s) -
Itaru Miura,
Kei Watabe,
Reiko Sakaguchi,
Keisuke Okamoto,
Hidenori Maruyama
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s380627
Subject(s) - lurasidone , positive and negative syndrome scale , medicine , discontinuation , adverse effect , tolerability , clinical global impression , schizophrenia (object oriented programming) , clinical endpoint , psychiatry , gastroenterology , clinical trial , antipsychotic , placebo , psychosis , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom